Psychiatr. praxi. 2011;12(3):108-111

Application of continuous glucose monitoring system in psychotic phase

MUDr.Eva Elšíková1,2,3, MUDr.Iveta Poljaková1
1 Ústav fyziologie, Lékařská fakulta Univerzity Palackého v Olomouci
2 Psychiatrická léčebna v Kroměříži
3 Psychosociální centrum v Přerově

Psychotic state as a emotional stressor for organism may be considered to cause fluctuations of glycemia.

In a case study, the authors describe the use of monitor and subcutaneous sensor Guardian REAL-Time CGMS produced by Medtronic in

a psychotic subject with diabetes mellitus. They evaluate the feasibility of this method in this clinical condition and mention eventual

pitfalls in result interpretation. They discuss the up to date evidence concerning the influence of mood and emotions on glycemia. They

suggest possible improvements of the method.

Keywords: glycemia, continuous glucose monitoring, emotion, mood, psychotic state, metabolism

Published: July 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Elšíková E, Poljaková I. Application of continuous glucose monitoring system in psychotic phase. Psychiatr. praxi. 2011;12(3):108-111.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chlup R, Peterson K, Zapletalová J, et al. Relation between HbA1c and average one-month interstitial fluid glucose concentration (ISFG) determined by continuous glucose monitoring - preliminary results of an ongoing study. Diabetes 2007; 56(Suppl 1): A527.
    2. Chlup R, Jelenová D, Chlupová K, et al. Function and accuracy of glucose sensors beyond their stated expiry date. Diabetes Technol Ther; 2006: 8(4). Go to original source... Go to PubMed...
    3. Jadviščoková T, Fajkusová Z, Pallayová M, et al. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacký Olomouc Czech Rep. 2007; 151(2): 263-266. Go to original source... Go to PubMed...
    4. Sim YB, Park SH, Kang YJ, et al. The regulation of blood glucose level in physical and emotional stress models: possible involvement of adrenergic and glucocorticoid systems. Arch Pharm Res. 2010; 33(10): 1679-1683. Go to original source... Go to PubMed...
    5. Mahl GF. Relationship between Acute and Chronic Fear and the Gastric Acidity and Blood Sugar Levels in Macaca mulatta Monkeys. Psychosomatic Medicine 1952; 14: 182-210. Go to original source... Go to PubMed...
    6. Whitehorn JC. The blood sugar in relation to emotional reactions. Am J Psychiatry 1934; 90: 987-1005. Go to original source...
    7. Armario A, Marti O, Molina T, et al. Acute stress markers in humans: response of plasma glucose, cortisol and prolactin to two examinations differing in the anxiety they provoke. Psychoneuroendocrinology 1996; 21(1): 17-24. Go to original source... Go to PubMed...
    8. Berndt-Zipfel C, Köthe L, Nawrodt B, et al. Glycaemic rises after waking up in response to an alarm clock in type 1-diabetic patients analysed with continuous glucose monitoring (GlucoDay(R) S). Exp Clin Endocrinol Diabetes 2011; 119(1): 56-58. Go to original source... Go to PubMed...
    9. Cox DJ, Taylor AG, Nowacek G, et al. The relationship between psychological stress and insulin-dependent diabetic blood glucose control: Preliminary investigations. Health Psychology 1984; 3(1): 63-75. Go to original source...
    10. Hermanns N, Scheff C, Kulzer B, et al. Association of glucose levels and glucose variability with mood in type 1 diabetic patients. Diabetologia 2007; 50: 930-933. Go to original source... Go to PubMed...
    11. Daniels GE. The role of emotion in the onset and course of diabetes. Psychosomatic Medicine 1948; 10: 288-290. Go to original source... Go to PubMed...
    12. Lustman PJ, Clouse RE. Treatment of depression in diabetes: Impact on mood and medical outcome. Journal of Psychosomatic Research 2002; 53(4): 917-924. Go to original source... Go to PubMed...
    13. Shomaker LB, Tanofsky-Kraff M, Young-Hyman D, et al. Psychological symptoms and insulin sensitivity in adolescents. Pediatr Diabetes 2010; 11(6): 417-423. Go to original source... Go to PubMed...
    14. Nagamine T. Abnormal laboratory values during the acute and recovery phases in schizophrenic patients: a retrospective study. Neuropsychiatr Dis Treat 2010; 24(6): 281-288. Go to original source...
    15. Dasgupta A, Singh OP, Rout JK, et al. Insulin resistance and metabolic profile in antipsychotic na?ve schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry 2010; 1,34(7): 1202-1207. Go to original source... Go to PubMed...
    16. Gordon, et al. The adrenalin glycemic curve as a diagnostic aid in psychiatry. Am J Psychiatry 1927; 84: 183-207. Go to original source...
    17. Katzenelbogen S, Friedman-Buchman E. Studies of blood sugar curves in mental disorders. Am J Psychiatry 1933; 90: 321-343. Go to original source...
    18. Robinson G, Jr. Incidence and interpretation of diabetic-like dextrose tolerance curves in nervous and mental patients: a study of sixty-nine. JAMA 1940; 114(23): 2279-2284. Go to original source...
    19. Shiloah E, Witz S, Abramovitch Y, et al. Effect of acute psychotic stress in nondiabetic subjects on beta-cell function and insulin sensitivity. Diabetes Care 2003; 26(10): 2967-2968. Go to original source... Go to PubMed...
    20. Rausch JR. Measures of glycemic variability and links with psychological functioning. Curr Diab Rep 2010; 10(6): 415-421. Go to original source... Go to PubMed...
    21. Bartášková D. Inzulinové pumpy v léčbě diabetu. MF mediREPORT příloha časopisu Tempus medicorum 2011; (2): 22-27.
    22. Peterson K. Kontinuální monitorování koncentrace glukózy - historie, současné možnosti a perspektivy. Interní Med. 2009; 11(Suppl B): B72-B77.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.